The crystal structure of (3S,8R,10R,14R)-17-((2S,5S)-5-(2-hydroxypropan-2-yl)-2-methyltetrahydrofuran-2-yl)-4,4,8,10,14-pentamethyl-12-oxohexadecahydro-1H-cyclopenta[a]phenanthren-3-yl acetate, C32H52O5

C32H52O5, monoclinic, P21 (no. 4), a = 11.816(2) Å, b = 7.4064(15) Å, c = 17.101(3) Å, β = 97.01(3)°, V = 1485.5(5) Å3, Z = 2, Rgt(F) = 0.0543, wRref(F2) = 0.1501, T = 293(2) K.

Bibliographic Details
Main Authors: Liu Li, Wang Hui-yun, Zhou Xia, Zhang Sheng-Nan, Chen Xiao-Qian, Zhao Feng-Lan, Meng Qing-Guo
Format: Article
Language:English
Published: De Gruyter 2020-10-01
Series:Zeitschrift für Kristallographie - New Crystal Structures
Subjects:
Online Access:https://doi.org/10.1515/ncrs-2020-0384
id doaj-109d7ceab9e0413ea5850b95cdd4ba5d
record_format Article
spelling doaj-109d7ceab9e0413ea5850b95cdd4ba5d2021-09-06T19:21:02ZengDe GruyterZeitschrift für Kristallographie - New Crystal Structures1433-72662197-45782020-10-0123561547154910.1515/ncrs-2020-0384ncrs-2020-0384The crystal structure of (3S,8R,10R,14R)-17-((2S,5S)-5-(2-hydroxypropan-2-yl)-2-methyltetrahydrofuran-2-yl)-4,4,8,10,14-pentamethyl-12-oxohexadecahydro-1H-cyclopenta[a]phenanthren-3-yl acetate, C32H52O5Liu Li0Wang Hui-yun1Zhou Xia2Zhang Sheng-Nan3Chen Xiao-Qian4Zhao Feng-Lan5Meng Qing-Guo6School of Pharmacy, Collaborative Innovation Center of Advanced Drug Delivery, System and Biotech Drugs in Universities of Shandong, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Yantai University, Yantai, P.R. ChinaCollege of Pharmacy, Jining Medical University, Rizhao, 276826, P.R. ChinaSchool of Pharmacy, Collaborative Innovation Center of Advanced Drug Delivery, System and Biotech Drugs in Universities of Shandong, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Yantai University, Yantai, P.R. ChinaSchool of Pharmacy, Collaborative Innovation Center of Advanced Drug Delivery, System and Biotech Drugs in Universities of Shandong, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Yantai University, Yantai, P.R. ChinaSchool of Pharmacy, Collaborative Innovation Center of Advanced Drug Delivery, System and Biotech Drugs in Universities of Shandong, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Yantai University, Yantai, P.R. ChinaSchool of Pharmacy, Collaborative Innovation Center of Advanced Drug Delivery, System and Biotech Drugs in Universities of Shandong, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Yantai University, Yantai, P.R. ChinaSchool of Pharmacy, Collaborative Innovation Center of Advanced Drug Delivery, System and Biotech Drugs in Universities of Shandong, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Yantai University, Yantai, P.R. ChinaC32H52O5, monoclinic, P21 (no. 4), a = 11.816(2) Å, b = 7.4064(15) Å, c = 17.101(3) Å, β = 97.01(3)°, V = 1485.5(5) Å3, Z = 2, Rgt(F) = 0.0543, wRref(F2) = 0.1501, T = 293(2) K.https://doi.org/10.1515/ncrs-2020-03842016696
collection DOAJ
language English
format Article
sources DOAJ
author Liu Li
Wang Hui-yun
Zhou Xia
Zhang Sheng-Nan
Chen Xiao-Qian
Zhao Feng-Lan
Meng Qing-Guo
spellingShingle Liu Li
Wang Hui-yun
Zhou Xia
Zhang Sheng-Nan
Chen Xiao-Qian
Zhao Feng-Lan
Meng Qing-Guo
The crystal structure of (3S,8R,10R,14R)-17-((2S,5S)-5-(2-hydroxypropan-2-yl)-2-methyltetrahydrofuran-2-yl)-4,4,8,10,14-pentamethyl-12-oxohexadecahydro-1H-cyclopenta[a]phenanthren-3-yl acetate, C32H52O5
Zeitschrift für Kristallographie - New Crystal Structures
2016696
author_facet Liu Li
Wang Hui-yun
Zhou Xia
Zhang Sheng-Nan
Chen Xiao-Qian
Zhao Feng-Lan
Meng Qing-Guo
author_sort Liu Li
title The crystal structure of (3S,8R,10R,14R)-17-((2S,5S)-5-(2-hydroxypropan-2-yl)-2-methyltetrahydrofuran-2-yl)-4,4,8,10,14-pentamethyl-12-oxohexadecahydro-1H-cyclopenta[a]phenanthren-3-yl acetate, C32H52O5
title_short The crystal structure of (3S,8R,10R,14R)-17-((2S,5S)-5-(2-hydroxypropan-2-yl)-2-methyltetrahydrofuran-2-yl)-4,4,8,10,14-pentamethyl-12-oxohexadecahydro-1H-cyclopenta[a]phenanthren-3-yl acetate, C32H52O5
title_full The crystal structure of (3S,8R,10R,14R)-17-((2S,5S)-5-(2-hydroxypropan-2-yl)-2-methyltetrahydrofuran-2-yl)-4,4,8,10,14-pentamethyl-12-oxohexadecahydro-1H-cyclopenta[a]phenanthren-3-yl acetate, C32H52O5
title_fullStr The crystal structure of (3S,8R,10R,14R)-17-((2S,5S)-5-(2-hydroxypropan-2-yl)-2-methyltetrahydrofuran-2-yl)-4,4,8,10,14-pentamethyl-12-oxohexadecahydro-1H-cyclopenta[a]phenanthren-3-yl acetate, C32H52O5
title_full_unstemmed The crystal structure of (3S,8R,10R,14R)-17-((2S,5S)-5-(2-hydroxypropan-2-yl)-2-methyltetrahydrofuran-2-yl)-4,4,8,10,14-pentamethyl-12-oxohexadecahydro-1H-cyclopenta[a]phenanthren-3-yl acetate, C32H52O5
title_sort crystal structure of (3s,8r,10r,14r)-17-((2s,5s)-5-(2-hydroxypropan-2-yl)-2-methyltetrahydrofuran-2-yl)-4,4,8,10,14-pentamethyl-12-oxohexadecahydro-1h-cyclopenta[a]phenanthren-3-yl acetate, c32h52o5
publisher De Gruyter
series Zeitschrift für Kristallographie - New Crystal Structures
issn 1433-7266
2197-4578
publishDate 2020-10-01
description C32H52O5, monoclinic, P21 (no. 4), a = 11.816(2) Å, b = 7.4064(15) Å, c = 17.101(3) Å, β = 97.01(3)°, V = 1485.5(5) Å3, Z = 2, Rgt(F) = 0.0543, wRref(F2) = 0.1501, T = 293(2) K.
topic 2016696
url https://doi.org/10.1515/ncrs-2020-0384
work_keys_str_mv AT liuli thecrystalstructureof3s8r10r14r172s5s52hydroxypropan2yl2methyltetrahydrofuran2yl4481014pentamethyl12oxohexadecahydro1hcyclopentaaphenanthren3ylacetatec32h52o5
AT wanghuiyun thecrystalstructureof3s8r10r14r172s5s52hydroxypropan2yl2methyltetrahydrofuran2yl4481014pentamethyl12oxohexadecahydro1hcyclopentaaphenanthren3ylacetatec32h52o5
AT zhouxia thecrystalstructureof3s8r10r14r172s5s52hydroxypropan2yl2methyltetrahydrofuran2yl4481014pentamethyl12oxohexadecahydro1hcyclopentaaphenanthren3ylacetatec32h52o5
AT zhangshengnan thecrystalstructureof3s8r10r14r172s5s52hydroxypropan2yl2methyltetrahydrofuran2yl4481014pentamethyl12oxohexadecahydro1hcyclopentaaphenanthren3ylacetatec32h52o5
AT chenxiaoqian thecrystalstructureof3s8r10r14r172s5s52hydroxypropan2yl2methyltetrahydrofuran2yl4481014pentamethyl12oxohexadecahydro1hcyclopentaaphenanthren3ylacetatec32h52o5
AT zhaofenglan thecrystalstructureof3s8r10r14r172s5s52hydroxypropan2yl2methyltetrahydrofuran2yl4481014pentamethyl12oxohexadecahydro1hcyclopentaaphenanthren3ylacetatec32h52o5
AT mengqingguo thecrystalstructureof3s8r10r14r172s5s52hydroxypropan2yl2methyltetrahydrofuran2yl4481014pentamethyl12oxohexadecahydro1hcyclopentaaphenanthren3ylacetatec32h52o5
AT liuli crystalstructureof3s8r10r14r172s5s52hydroxypropan2yl2methyltetrahydrofuran2yl4481014pentamethyl12oxohexadecahydro1hcyclopentaaphenanthren3ylacetatec32h52o5
AT wanghuiyun crystalstructureof3s8r10r14r172s5s52hydroxypropan2yl2methyltetrahydrofuran2yl4481014pentamethyl12oxohexadecahydro1hcyclopentaaphenanthren3ylacetatec32h52o5
AT zhouxia crystalstructureof3s8r10r14r172s5s52hydroxypropan2yl2methyltetrahydrofuran2yl4481014pentamethyl12oxohexadecahydro1hcyclopentaaphenanthren3ylacetatec32h52o5
AT zhangshengnan crystalstructureof3s8r10r14r172s5s52hydroxypropan2yl2methyltetrahydrofuran2yl4481014pentamethyl12oxohexadecahydro1hcyclopentaaphenanthren3ylacetatec32h52o5
AT chenxiaoqian crystalstructureof3s8r10r14r172s5s52hydroxypropan2yl2methyltetrahydrofuran2yl4481014pentamethyl12oxohexadecahydro1hcyclopentaaphenanthren3ylacetatec32h52o5
AT zhaofenglan crystalstructureof3s8r10r14r172s5s52hydroxypropan2yl2methyltetrahydrofuran2yl4481014pentamethyl12oxohexadecahydro1hcyclopentaaphenanthren3ylacetatec32h52o5
AT mengqingguo crystalstructureof3s8r10r14r172s5s52hydroxypropan2yl2methyltetrahydrofuran2yl4481014pentamethyl12oxohexadecahydro1hcyclopentaaphenanthren3ylacetatec32h52o5
_version_ 1717775372415664128